Long_Matthew_720x720473 W. 12th Ave.
DHLRI Room 201
Columbus, OH 43210


The main objectives of the laboratory are to understand the cellular and molecular mechanisms regulating pulmonary inflammation and its resolution, with the goal of developing anti-inflammatory or dual anti-microbial and anti-inflammatory therapeutics. We currently focus on two primary lung diseases: 1) Cystic Fibrosis (CF) and, 2) Acute Respiratory Distress Syndrome (ARDS), and are specifically interested in understanding how MAPK signaling pathways regulate leukocyte responses to inflammation and infection. Our laboratory utilizes both in vitro and in vivo models in our experimental design to investigate the regulators of inflammation.

Education and Training

Postdoctoral Fellowship: University of Washington, Seattle, WA
PhD: University of Iowa, Iowa City, IA
BS: Northern Illinois University, Dekalb, IL

Research Interests

  • Leukocyte regulation of pulmonary inflammation
  • MAPK regulation of leukocyte functions
  • Host defense and host-pathogen interactions
  • Microbial infections (Pseudomonas aeruginosa, Staphylococcus aureus)
  • Cystic Fibrosis
  • Acute Respiratory Distress Syndrome (ARDS)
  • Translational Therapeutics


  • Cystic Fibrosis Foundation Postdoc-to-Faculty Transition Award
  • Cystic Fibrosis Foundation Postdoctoral Fellowship
  • Society for Leukocyte Biology Presidential Award Finalist (Junior Faculty/Postdoctoral)
  • National Research Service Award NIH/NHLBI T32